Indian drugmaker Cipla misses Q4 profit view on weak US sales
Indian drugmaker Cipla misses Q4 profit view on weak US sales
Indian drugmaker Cipla misses Q4 profit view on weak US sales
Sector
HEALTHCARE
News Type
MARKET
Impact Level
HIGH
AI Sentiment
NEGATIVE
Published
13 May 2026
📎 Sources
Reuters | https://www.tradingview.com/news/reuters.com,2026:newsml_L4N41Q0KW:0-indian-drugmaker-cipla-misses-q4-profit-view-on-weak-us-sales/